HIF2Again-of-function mutations detected in duodenal gangliocytic paraganglioma

Polycythemia and Paraganglioma With a Novel Somatic HIF2A Mutation in a Male

(2014) H. Toyoda et al.   PEDIATRICS

In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas

(2013) Rodrigo A Toledo et al.   ENDOCRINE-RELATED CANCER

Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis

(2013) Iñaki Comino-Méndez et al.   HUMAN MOLECULAR GENETICS

New Syndrome of Paraganglioma and Somatostatinoma Associated With Polycythemia

(2013) Karel Pacak et al.   JOURNAL OF CLINICAL ONCOLOGY

SomaticHIF2AGain-of-Function Mutations in Paraganglioma with Polycythemia

(2012) Zhengping Zhuang et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Approach to the Patient with Paraganglioma

(2009) Hartmut P. H. Neumann et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

HIF-2  maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells

(2009) A. Pietras et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA